U.S. Basic Materials Stock News

Wave Life Sciences reported past first-quarter 2026 results with sales rising to US$38.25 million from US$9.18 million and its net loss narrowing to US$26.09 million, alongside a smaller basic loss per share of US$0.13. Beyond the headline numbers, investors are focused on how Wave’s progressing RNA pipeline and advancing obesity and AATD programs intersect with improving quarterly performance. We’ll now examine how Wave’s stronger-than-expected revenue and reduced quarterly loss reshape its...

Generac Holdings (GNRC) has just opened its Q1 2026 earnings season story, with investors focused on how the recent quarterly swings in revenue and EPS set up the next leg for margins. Over the past six quarters, total revenue has ranged from US$942.1 million in Q1 2025 to US$1.23 billion in Q4 2024, while quarterly basic EPS has moved between a loss of US$0.42 in Q4 2025 and a peak of US$2.18 in Q4 2024. This sets a mixed backdrop for the latest release and puts the spotlight firmly on how...

Kite Realty Group Trust (KRG) opened 2026 with Q1 results framed by recent trailing revenue of US$844.4 million and basic EPS of US$1.37, while FFO over the same trailing period stood at US$458.6 million, or US$2.06 per share. Over the past few quarters, total revenue has ranged from US$207.3 million to US$221.8 million as basic EPS moved between US$0.08 and US$0.84. This gives you a clear view of how the income statement has tracked alongside FFO. With reported net profit margins recently...

LendingClub stock snapshot and recent performance LendingClub (LC) has drawn attention after recent share price moves, with the stock closing at US$16.55 and showing mixed returns over different holding periods, including the past week, month, and past 3 months. See our latest analysis for LendingClub. The recent 1 day share price return of a 1.90% decline and 7 day share price return of a 6.92% decline sit against a 30 day share price return of 19.84% and a 1 year total shareholder return of...

American Assets Trust (AAT) opened 2026 with Q1 revenue of US$110.6 million and basic EPS of US$0.08, while Funds From Operations came in at US$38.8 million as the key REIT profitability measure. Over the past few quarters the company has seen revenue move between US$106.9 million and US$112.2 million, with basic EPS ranging from US$0.05 to a very large spike above US$0.70 in early 2025, underscoring how earnings have shifted around headline events even as FFO stayed in a tighter band. For...

Chewy (NYSE:CHWY) is refocusing on Net Sales Per Active Customer as a key growth driver, alongside customer additions. The company is expanding its health ecosystem, including veterinary care and pharmacy services, to deepen customer engagement. Management is now explicitly linking future sales growth to a blend of higher spending per user and ecosystem expansion. Chewy enters this shift with a share price of $25.96 and a mixed recent track record, including a 4.0% decline over the past...

Hub Group (NasdaqGS:HUBG) shares have strongly outperformed the S&P 500 over the past six months. This share price strength comes alongside ongoing concerns about slow long-term revenue growth. Investors are also watching a trend of declining return on invested capital over time. Hub Group is a major player in asset light freight transportation and logistics, a space that has been reshaped by shifts in shipping volumes, supply chain reliability, and customer expectations. The recent share...

Pomerantz LLP has filed a class action lawsuit against Babcock & Wilcox Enterprises (BW), sharpening focus on the company’s disclosures, governance, and high profile power contracts that previously attracted significant investor attention. See our latest analysis for Babcock & Wilcox Enterprises. Despite legal headlines, the stock has been volatile rather than moving in a single direction. It has a 1 day share price return of 1.09%, a 30 day share price return of 11.88%, and a year to date...

Silicon Motion Technology Corporation previously confirmed its annual dividend of US$2.00 per ADS (US$0.50 per ordinary share), with the next quarterly installment of US$0.50 per ADS (US$0.125 per ordinary share) scheduled to be paid on May 21, 2026 to shareholders of record on May 7, 2026. Alongside this ongoing dividend commitment, the company has reported several quarters of strong revenue growth and market share gains across AI, automotive, and enterprise storage controllers, underpinned...

Ribbon Communications (RBBN) opened Q1 2026 with revenue of US$162.6 million and a basic EPS loss of US$0.20, alongside net income excluding extra items of a US$34.5 million loss, setting a cautious tone around profitability. Over the past six reported quarters, revenue has moved from US$251.4 million in Q4 2024 to US$181.3 million in Q1 2025, then to US$227.3 million in Q4 2025 and US$162.6 million in Q1 2026, while quarterly basic EPS has swung between a US$0.51 profit in Q4 2025 and losses...

Brinker International (EAT) has put up another solid set of numbers for Q3 2026, with Q2 fiscal revenue at US$1.45b, basic EPS of US$2.92 and net income of US$128.5 million, backed by 7.5% same restaurant sales growth across 1,627 locations. The company has seen revenue move from US$1.36b and EPS of US$2.67 in Q2 2025 to US$1.45b and EPS of US$2.92 in Q2 2026. Trailing 12 month figures show revenue of US$5.69b and EPS of US$10.22, setting a clear context for year on year earnings growth of...

The FDA's Center for Drug Evaluation and Research has proposed that Amgen withdraw its drug Tavneos, citing untrue statements of material facts and possible data manipulation in clinical trial data. Regulators also questioned whether existing evidence is sufficient to support Tavneos's effectiveness. The proposal raises concerns about Amgen's regulatory controls, data transparency, and risk oversight as the company grows in biopharmaceuticals. For investors watching Amgen, ticker...

Eaton (ETN) is drawing attention after a recent move in its share price, with the stock showing mixed short term returns despite a positive month and past 3 months performance profile. See our latest analysis for Eaton. The recent pullback, with a 1-day share price return of 0.56% and 7-day share price return of 0.75%, sits against a 30-day share price return of 19.57% and a 1-year total shareholder return of 41.25%. If Eaton's move has you watching the power and infrastructure space more...

New Navy task order puts fresh attention on SAIC Science Applications International (SAIC) just secured a new US$75.2 million task order to support Naval Air Systems Command, highlighting the company’s role in digital engineering, predictive analytics, and long running Navy programs. See our latest analysis for Science Applications International. The new Navy task order comes at a time when the share price is around US$95.13, with a 90 day share price return of a 6.52% decline and a 1 year...

Wondering if GXO Logistics at around US$55 a share still offers value, or if most of the opportunity is already priced in. The stock has had a mixed short term patch, with a 3.9% decline over the last 7 days, a 12.9% gain over the last 30 days, a 1.6% return year to date, and a 52.2% return over the past year. Recent coverage has focused on GXO Logistics as a pure play contract logistics provider and how its role in global supply chains frames investor expectations. Ongoing commentary around...

ICF International (ICFI) has drawn investor attention after recent share price swings, including a decline of about 26% over the past 3 months, prompting a closer look at its current valuation and fundamentals. See our latest analysis for ICF International. While the share price has recently been under pressure, with a 90 day share price return of about negative 26.5% and a 1 year total shareholder return of about negative 19%, the past month’s share price recovery suggests some short term...

Envista Holdings overview and recent share performance Envista Holdings (NVST) has drawn investor attention after recent share price moves, with the stock showing a mix of short term weakness over the past week and a gain over the past month. Over the past day Envista recorded a 2.2% decline, with a 4.6% decline across the past week. That contrasts with a positive return over the past month and past 3 months, alongside a higher total return over the past year. See our latest analysis for...

In recent days, Marvell Technology canceled all Celestial AI-related purchase orders after accusing POET Technologies of breaching confidentiality by publicly disclosing sensitive order details. This dispute highlights how Marvell’s push deeper into custom AI and photonics partnerships also increases its exposure to complex supplier and confidentiality risks. We’ll now examine how canceling Celestial AI-linked orders after POET’s confidentiality breach affects Marvell’s AI-focused...

In late April 2026, Cisco Systems announced its Universal Quantum Switch, a room-temperature device designed to route and convert quantum information across multiple encoding types over standard telecom fiber while preserving coherence, alongside strong Q2 FY2026 results driven by AI-focused infrastructure demand and raised full-year guidance. This combination of cutting-edge quantum networking research and AI-oriented networking momentum underlines Cisco’s ambition to build a full-stack...

Why IPG Photonics (IPGP) is back on investors’ radar IPG Photonics (IPGP) has drawn fresh attention after recent trading, with the stock closing at $113.26 and short term returns sending mixed signals across the past week, month, and past 3 months. See our latest analysis for IPG Photonics. The recent 1 day share price return of 0.80% comes after a weaker 7 day patch and a modest 30 day decline. However, the 90 day share price return of 22.56% and year to date share price return of 51.34% sit...

If you are wondering whether IDEXX Laboratories at around US$553.66 is still a quality opportunity or already pricing in a lot of optimism, the next sections walk through what the current valuation is actually telling you. Over the last week and month, the share price is modestly lower, with returns of a 1.3% decline and a 1.5% decline, while the longer-term picture shows 17.5% over 1 year and 17.9% over 3 years, with 3.8% over 5 years and a 17.4% decline year to date. Recent coverage has...

If you are wondering whether Radian Group at around US$37.31 still offers value, the key question is how its current price compares with what the business may reasonably be worth. The stock has recently shown solid returns, with 4.9% over the last 7 days, 12.8% over 30 days, 3.9% year to date, 20.3% over 1 year, 73.2% over 3 years, and 86.2% over 5 years. Recent coverage has focused on Radian Group's position in the diversified financials space and how the market is reassessing risk and...

For investors wondering whether CarGurus at around US$36.67 is still offering value or if the easy gains are behind it, this piece focuses on what the current price implies. The stock has returned 31.4% over the last year, with a 7.7% move over the past month and a 2.2% pullback in the last week that may have shifted the near term risk reward balance. Recent coverage has focused on CarGurus as an established online auto marketplace and its role in connecting dealers and car buyers. This...

Dyne Therapeutics, Inc. recently announced preclinical data showing its FORCE platform can cross the blood-brain barrier and achieve robust MAPT RNA knockdown in the central nervous system in mice and nonhuman primates, using two TfR1-targeting siRNA conjugates that also worked via subcutaneous dosing. This work suggests Dyne’s clinically validated FORCE platform, originally built for neuromuscular diseases, may be extendable to neurological conditions linked to tau pathology such as...